What does CUSIP 81728J109 represent in this 13F holders report?

CUSIP 81728J109 is the security identifier for SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value used to aggregate holder disclosures.

How many institutions held SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value in Q1 2026?

40 institutional investors reported SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value for Q1 2026. Use the holders table for investor-level position and value details.

Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)

CUSIP: 81728J109

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, $0.01 par value
Total 13F shares: 3,949,816
Total 13F value: $15,719,197
Share change: -105,364
Put/Call ratio: 0%
SEC-reported price per share: $3.98
Number of holders: 40
Value change: -$422,947
Number of buys: 12
Number of sells: 20
Shares outstanding: 16,385,263

Security key

81728J109

Report period

Q1 2026

Institutions

Top holders

SRTS full security history Ownership snapshot Full 13F holder table Sensus Healthcare, Inc. SEC filings Sensus Healthcare, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Edwin L. Solot Jr.

Disclosed value leader

Edwin L. Solot Jr.

Comparable rows

15/15

Latest evidence

31 Dec 2025

13D/G 3/4/5 13F Lead comparable stake: 7.6% 13D/G row: Edwin L. Solot Jr. Showing 1-6 of 15 holder rows.

Quick read

Edwin L. Solot Jr. leads the comparable SEC ownership view at 7.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Edwin L. Solot Jr.'s linked filing trail.

Comparable ownership Top 5

Edwin L. Solot Jr. 7.6%

Joseph C. Sardano 7.1%

Michael Sardano 0.98%

Magdalena Martinez 0.07%

VANGUARD GROUP INC 4.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Edwin L. Solot Jr.	13D/G 13D/G	7.6%	$5,827,910 1,245,280 shares	$0	31 Dec 2024
Joseph C. Sardano	3/4/5 13D/G CHIEF EXECUTIVE OFFICER, Director 3/4/5 13D/G	7.1% from 13D/G	$4,837,180 1,200,293 shares	+$100,750	18 Nov 2025
Michael Sardano	3/4/5 PRESIDENT AND GENERAL COUNSEL, Director 3/4/5	0.98%	$645,749 159,839 shares	+$8,546	12 Dec 2025
Magdalena Martinez	3/4/5 CHIEF OPERATING OFFICER 3/4/5	0.07%	$47,090 12,013 shares	—	19 Dec 2023
VANGUARD GROUP INC	13F Company 13F	4.4%	$2,901,086 728,916 shares	—	31 Dec 2025
Pacific Ridge Capital Partners, LLC	13F Company 13F	4.3%	$2,780,563 698,634 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,949,816

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %